ADMA icon

ADMA Biologics

56 hedge funds and large institutions have $84.5M invested in ADMA Biologics in 2019 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 13 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding:

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

5.18% less ownership

Funds ownership: 53.28%48.1% (-5.2%)

84% less call options, than puts

Call options by funds: $297K | Put options by funds: $1.81M

Holders
56
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$297K
Puts
$1.81M
Net Calls
Net Calls Change

Top Buyers

1 +$1.28M
2 +$853K
3 +$663K
4
Barclays
Barclays
United Kingdom
+$210K
5
Jane Street
Jane Street
New York
+$177K

Top Sellers

1 -$10.4M
2 -$1.23M
3 -$205K
4
Morgan Stanley
Morgan Stanley
New York
-$96.9K
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
-$90.8K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$24.7M
2
$17.4M
3
$13.7M
4
$6.3M
5
$5.61M
6
$3.71M
7
$3.05M
8
$2.18M
9
$1.22M
10
$1.2M
11
$991K
12
$853K
13
$379K
14
$241K
15
$233K
16
$230K
17
$211K
18
$207K
19
$177K
20
$171K
21
$166K
22
$148K
23
$117K
24
$100K
25
$99K